Some protocols use somewhat distinctive schedules. Medical trials examined various escalation designs, which include jumping from four mg on to eight mg. The desk over reflects essentially the most gradual approach, which tends to make less side effects.The FDA has issued specific warnings about compounded or "analysis" versions of retatrutide boug